DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Liu G, Oettel K, Ripple G, Staab MJ, Horvath D, Alberti D, Arzoomanian R, Marnocha R, Bruskewitz R, Mazess R.
Phase I trial of 1α-hydroxyvitamin D2 in patients with hormone refractory prostate cancer.
Clin Cancer Res 2002;
8: 2820-2827
We do not assume any responsibility for the contents of the web pages of other providers.